Vision Zero Cancer is active in European research and innovation projects and other collaborations to accelerate the equitable implementation of precision diagnostics and treatment for cancer patients.
EU Projects
Vision Zero Cancer is an active partner in several projects funded by the European Union. EU Cancer Mission is the forefront of pioneering cancer projects aimed at revolutionizing the way we understand, diagnose, and treat cancer. These projects bring together leading researchers, healthcare professionals, and innovators from across the continent to collaborate on groundbreaking initiatives.
Personalised Cancer Medicine for Europe
PCM4EU, is a project under the Europe’s Beating Cancer Plan by EU4Health. PCM4EU is about facilitating implementation of molecular cancer diagnostics for precision oncology, and the consortium consists of partners from altogether 15 countries across Europe.
Learn more about PCM4EU
Establishing Cancer Mission Hubs: Networks and Synergies
ECHoS, is a project aiming to ensure the implementation of the Cancer Mission activities in all member states by establishing and developing Cancer Mission Hubs operating at national, regional, and local levels.
Learn more about ECHoS
European precision cancer medicine trial network
The PRIME-ROSE project builds on a bottom-up, clinician-initiated family of PCM clinical trials which have been particularly successful in bringing up inclusion rates to offer additional lines of treatment and in providing patient benefit.
Learn more about PRIME-ROSE
Memberships
Vision Zero Cancer’s memberships in various cancer-focused organizations is instrumental in driving advancements in cancer care and addressing the diverse needs of patients and stakeholders within cancer communities. These memberships facilitate collaboration, knowledge sharing, and advocacy efforts aimed at improving outcomes and enhancing support for those affected by cancer.
All. Can
Driving sustainable healthcare solutions for everyone affected by cancer. We imagine a world in which patients are always at the heart of cancer care. All.Can is an international multi-stakeholder not-for-profit organisation working to improve the efficiency of cancer care by focusing on what matters to patients.
Learn more
Community 365 European Cancer Organisation
A group of charity, philanthropy and industry contributors to the Focused Topic Networks of the European Cancer Organisation. Community 365 provide ideas, guidance, practical support and resources for our work in convening stakeholders and building consensus in the European cancer community.
Learn more
DIGICORE
A pan-European research network built to accelerate the Implementation of precision oncology in Europe. DIGICORE promotes and equips cancer centres in their use of routine electronic health records (EHR) and molecular diagnostic information (MDX) for trial automation, real world outcomes research, digital diagnostics and care quality management.
Learn more
SweCare
Developing Global Partnerships in Health, Swecare creates meeting places where the Swedish life science sector can strengthen their international relationships. Swecare is a unique non-profit platform where academia, public and private sector join forces toward enhanced export and internationalization of Swedish health care and life science.
Learn more
More collaborations
Dutch-Nordic Clinical Trial Network
The Nordic countries (Denmark, Sweden, Norway, and Finland) are setting up national clinical precision cancer trials together, modeled on the very successful DRUP trial in the Netherlands. The Drug Rediscovery Protocol (DRUP trial) is a national Dutch multi-center, multi-drug, pan-cancer basket trial in which patients with an incurable malignancy, who have exhausted standard treatment options, are treated off label with registered targeted therapies and immune checkpoint inhibitors, based on their tumor molecular profile.
Learn more